Aims and Scope
ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA).
Key Metrics
6.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.96
5-Year SI
5-year SI
- N/A 2-year SI
- 0.95 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Biochemistry
SJR
- Q2 Biochemistry
- Q2 Drug Discovery
- Q1 Organic Chemistry
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.93
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
60%
4 to 6 months
36%
7 to 9 months
4%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Pyrimidine
- Drug discovery
- Oral administration
- Amide
- Dihydrofolate reductase
- Mass spectrometry
- Protein degradation
- Anti-inflammatory
- Tyrosine kinase
- Pyrrolidine
- Cancer therapy
- Medicinal chemistry
- Furin
- Generative Design
- Biological evaluation
- B-cell lymphoma
- Parallel optimization
- Positron emission tomography
- Betulinic acid
- Hepatitis B
Journal Specifications
| Overview | |
| Publisher | AMER CHEMICAL SOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in ACS Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design
- 6 Nov 24
- ACS Medicinal Chemistry Letters
-
Full paper
Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors
- 5 Nov 24
- ACS Medicinal Chemistry Letters
-
Full paper
Discovery of <scp>l</scp>-Lysine Dioxalate (LH1513) as a Novel Inhibitor of Calcium Oxalate Crystallization for Hyperoxaluria
- 4 Nov 24
- ACS Medicinal Chemistry Letters
-
Full paper
Novel Aminopyrazole Inhibitors of PDE11A for the Treatment of Alzheimer’s Disease and Other Types of Dementia
- 4 Nov 24
- ACS Medicinal Chemistry Letters
-
Full paper
Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer’s Disease and Parkinson’s Disease
- 4 Nov 24
- ACS Medicinal Chemistry Letters
-
Full paper
Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in Development
- 4 Nov 24
- ACS Medicinal Chemistry Letters
Scite analysis
Powered by scite_
4.5k articles received 75.3k citations see all
- 2,030 Supporting
- 72,687 Mentioning
- 95 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 0 Corrections
- 23 Errata
- 0 Expression of Concern
FAQs
How long has ACS Medicinal Chemistry Letters been actively publishing?
ACS Medicinal Chemistry Letters has been in operation since 2010 till date.
What is the publishing frequency of ACS Medicinal Chemistry Letters ?
ACS Medicinal Chemistry Letters published with a Monthly frequency.
How many articles did ACS Medicinal Chemistry Letters publish last years ?
In 2023, ACS Medicinal Chemistry Letters published 363 articles.
What is the eISSN & pISSN for ACS Medicinal Chemistry Letters ?
For ACS Medicinal Chemistry Letters,eISSN is 1948-5875 and pISSN is1948-5875.
What is Citescore for ACS Medicinal Chemistry Letters ?
Citescore for ACS Medicinal Chemistry Letters is 6.6.
What is SNIP score for ACS Medicinal Chemistry Letters ?
SNIP score for ACS Medicinal Chemistry Letters is 0.93.
What is the SJR for ACS Medicinal Chemistry Letters ?
SJR for ACS Medicinal Chemistry Letters is Q2.
Who is the publisher of ACS Medicinal Chemistry Letters ?
AMER CHEMICAL SOC is the publisher of ACS Medicinal Chemistry Letters.